Literature DB >> 21402743

Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.

Adriano Chiò1, Andrea Calvo, Cristina Moglia, Letizia Mazzini, Gabriele Mora.   

Abstract

BACKGROUND: Different amyotrophic lateral sclerosis (ALS) phenotypes have been recognised, marked by a varying involvement of spinal and bulbar upper and lower motor neurons. However, the differential characteristics of these phenotypes are still largely unknown.
OBJECTIVE: To define the epidemiology and outcome of ALS phenotypes in a population based setting.
METHODS: All ALS cases incident in two Italian regions were prospectively collected from 1995 to 2004 in an epidemiological register. Cases were classified according to established ALS phenotypes: classic, bulbar, flail arm, flail leg, pyramidal, respiratory, pure lower motor neuron (PLMN) and pure upper motor neuron (PUMN).
RESULTS: ALS phenotype were determined in 1332 out of 1351 incident patients (98.6%). Classic and bulbar phenotypes had similar mean annual incidence rates. Gender specific incidence rates showed a male preponderance in respiratory, flail arm, classic and PLMN phenotypes; in all other phenotypes, men and women had similar incidence rates. Age at onset was significantly lower in pyramidal, PLMN and PUMN phenotypes and higher in the bulbar phenotype. The best outcomes were observed in PUMN, pyramidal, PLMN and flail arm phenotypes and the worst in respiratory and bulbar phenotypes.
CONCLUSIONS: Our epidemiological findings suggest that ALS phenotypes carry distinctive and easily distinguishable clinical and prognostic characteristics, strongly related to a complex interplay between gender and age. The categorisation of ALS patients according to more homogenous clinical groups is relevant in identifying biological markers for ALS and should be considered for the design of clinical trials.

Entities:  

Mesh:

Year:  2011        PMID: 21402743     DOI: 10.1136/jnnp.2010.235952

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  148 in total

Review 1.  How can we improve clinical trials in amyotrophic lateral sclerosis?

Authors:  Paul H Gordon; Vincent Meininger
Journal:  Nat Rev Neurol       Date:  2011-09-27       Impact factor: 42.937

Review 2.  Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Jeffrey M Statland; Richard J Barohn; April L McVey; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 3.  Amyotrophic Lateral Sclerosis Regional Variants (Brachial Amyotrophic Diplegia, Leg Amyotrophic Diplegia, and Isolated Bulbar Amyotrophic Lateral Sclerosis).

Authors:  Omar Jawdat; Jeffrey M Statland; Richard J Barohn; Jonathan S Katz; Mazen M Dimachkie
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 4.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

5.  Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease.

Authors:  Alessandra Gaiani; Ilaria Martinelli; Luca Bello; Giorgia Querin; Marco Puthenparampil; Susanna Ruggero; Elisabetta Toffanin; Annachiara Cagnin; Chiara Briani; Elena Pegoraro; Gianni Sorarù
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

Review 6.  Amyotrophic lateral sclerosis: cell vulnerability or system vulnerability?

Authors:  Kevin Talbot
Journal:  J Anat       Date:  2013-09-08       Impact factor: 2.610

7.  Disease progression in C9orf72 mutation carriers.

Authors:  Mary K Floeter; Bryan J Traynor; Jennifer Farren; Laura E Braun; Michael Tierney; Edythe A Wiggs; Tianxia Wu
Journal:  Neurology       Date:  2017-06-14       Impact factor: 9.910

8.  Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.

Authors:  Jessica Mandrioli; Sara Angela Malerba; Ettore Beghi; Nicola Fini; Antonio Fasano; Elisabetta Zucchi; Silvia De Pasqua; Carlo Guidi; Emilio Terlizzi; Elisabetta Sette; Alessandro Ravasio; Mario Casmiro; Fabrizio Salvi; Rocco Liguori; Lucia Zinno; Yasmin Handouk; Romana Rizzi; Annamaria Borghi; Rita Rinaldi; Doriana Medici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Marina Aiello; Salvatore Ferro; Marco Vinceti
Journal:  J Neurol       Date:  2018-02-05       Impact factor: 4.849

9.  Acoustic reflex patterns in amyotrophic lateral sclerosis.

Authors:  Andrea Canale; Roberto Albera; Michelangelo Lacilla; Antonio Canosa; Andrea Albera; Francesca Sacco; Adriano Chiò; Andrea Calvo
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-30       Impact factor: 2.503

Review 10.  Electrodiagnosis in persons with amyotrophic lateral sclerosis.

Authors:  Nanette C Joyce; Gregory T Carter
Journal:  PM R       Date:  2013-03-21       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.